CYP2C19 and stroke disorder: The loss-of-function allele for the CYP2C19 gene was approximately 30% of the US population and 60% in Chinese populations, clopidogrel plus aspirin reduced the risk of a new stroke only in the subgroup of patients who were not carriers of the CYP2C19 loss-of-function alleles [25].